Abstract | OBJECTIVES: PATIENTS AND METHODS:
Amphotericin B tissue levels were measured in liver, spleen, lung, kidney, and myocardial and brain tissue of 20 patients who had been treated with lipid-formulated amphotericin B, before they died from multi-organ failure. Seven patients had been treated with liposomal amphotericin B ( AmBisome) and thirteen with colloidal amphotericin B ( Amphocil). Tissue samples were obtained during routine autopsy, homogenized and extracted with methanol. Amphotericin B concentrations were measured using HPLC after purification by solid phase extraction. RESULTS: CONCLUSIONS:
|
Authors | Helene Vogelsinger, Stefan Weiler, Angela Djanani, Jordan Kountchev, Rosa Bellmann-Weiler, Christian J Wiedermann, Romuald Bellmann |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 57
Issue 6
Pg. 1153-60
(Jun 2006)
ISSN: 0305-7453 [Print] England |
PMID | 16627591
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Tissue Extracts
- liposomal amphotericin B
- Amphotericin B
|
Topics |
- Adult
- Aged
- Amphotericin B
(analysis, pharmacokinetics)
- Autopsy
- Brain Chemistry
- Chromatography, High Pressure Liquid
- Female
- Humans
- Kidney
(chemistry)
- Liver
(chemistry)
- Lung
(chemistry)
- Male
- Middle Aged
- Multiple Organ Failure
- Mycoses
(complications, drug therapy)
- Myocardium
(chemistry)
- Spleen
(chemistry)
- Tissue Distribution
- Tissue Extracts
(chemistry, isolation & purification)
|